Debt-to-equity of Design Therapeutics, Inc. from 30 Sep 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Design Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 31 Dec 2025.
  • Design Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 5.3%, a 48% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Design Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 5.3% +1.7% +48% 31 Dec 2025
Q3 2025 4.7% +1% +29% 30 Sep 2025
Q2 2025 4.1% +0.06% +1.5% 30 Jun 2025
Q1 2025 3.8% -0.74% -16% 31 Mar 2025
Q4 2024 3.6% -0.99% -22% 31 Dec 2024
Q3 2024 3.6% -0.89% -20% 30 Sep 2024
Q2 2024 4.1% -0.18% -4.2% 30 Jun 2024
Q1 2024 4.5% +0.76% +20% 31 Mar 2024
Q4 2023 4.6% +1.2% +37% 31 Dec 2023
Q3 2023 4.5% +1.7% +59% 30 Sep 2023
Q2 2023 4.2% +1.8% +75% 30 Jun 2023
Q1 2023 3.8% +1.9% +98% 31 Mar 2023
Q4 2022 3.4% +1.8% +115% 31 Dec 2022
Q3 2022 2.8% +1.3% +82% 30 Sep 2022
Q2 2022 2.4% 30 Jun 2022
Q1 2022 1.9% 31 Mar 2022
Q4 2021 1.6% 31 Dec 2021
Q3 2021 1.6% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.